Parallax Volatility Advisers
SNDX icon

Parallax Volatility Advisers’s Syndax Pharmaceuticals SNDX Stock Holding History

Parallax Volatility Advisers’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-41,985
Closed -$907K – 2305
2023
Q4 		$907K Buy
41,985
+28,197
+205% +$433K ﹤0.01% 1446
2023
Q3 		$200K Buy
+13,788
New +$261K ﹤0.01% 1823
2018
Q1 		– Sell
-1,596
Closed -$14K – 4018
2017
Q4 		$14K Buy
+1,596
New +$15.8K ﹤0.01% 3753

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Parallax Volatility Advisers's SNDX Position: Q1 2024 in Review

Parallax Volatility Advisers sold out of Syndax Pharmaceuticals (SNDX) in Q1 2024, closing a stake of 41,985 shares — an estimated $907K sold.

Parallax Volatility Advisers first reported a position in SNDX in Q4 2017 and held it in 3 quarters. The position peaked at $907K in Q4 2023. 189 funds tracked by Wall St. Rank hold SNDX as of Q1 2024.

  • Parallax Volatility Advisers reported no remaining Syndax Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 41,985 Syndax Pharmaceuticals shares in Q1 2024, an estimated $907K.
  • Parallax Volatility Advisers first reported a position in Syndax Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Parallax Volatility Advisers's Syndax Pharmaceuticals position peaked at $907K in Q4 2023.
  • 189 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2024.

Based on Parallax Volatility Advisers's 13F filing for Q1 2024, filed 15 May 2024.